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Abstract
Introduction: The current study aimed to assess the interference of in vitro haemolysis on complete blood count (CBC) using Abbott Alinity hq 
system, and to determine which haemolysis levels affect the reliability of sample results. 
Materials and methods: Blood samples obtained from 25 volunteers in K3-EDTA tubes were divided into four aliquots. The first aliquot was not 
subjected to any intervention. The second, third and fourth aliquots were passed through a fine needle 2, 4 and 6 times, respectively. Complete blo-
od count was performed by multi-angle polarized scatter separation technology and haemolysis index (HI) was assessed from the plasma samples 
separated by centrifugation. Five groups were formed according to the HI values. The percentage biases between the results of non-haemolysed 
and haemolysed groups were compared with the desirable bias limits from The European Federation of Clinical Chemistry and Laboratory Medicine 
database and reference change values (RCVs). 
Results: In groups 1 to 4, the effects of haemolysis on CBC parameters were acceptable comparing to the analytical bias except for lymphocytes 
(7.26%-7.42%), MCH (2.59%), and MCHC (0.47%-2.81%). Results of group 5 (gross haemolysis) showed decreases in HCT(- 4.56%), RBC (- 4.07%) 
count and increase in lymphocyte (11.60%) count higher than the analytical performance specifications. Moreover, variations in MCH (4.65%) and 
MCHC (5.24%) were exceeding the RCVs.  
Conclusions: Gross haemolysis (haemoglobin concentration > 10 g/L) is likely to produce unreliable CBC results on non-pathological samples. 
Further studies including pathological specimens are needed.
Keywords: complete blood count; reference change values; haemolysis; interference
Submitted: May 25, 2021 Accepted: August 28, 2021
Effects of specimen haemolysis on complete blood count results by Abbott 
Alinity hq System
Müjgan Ercan*1, Emiş Deniz Akbulut2, Nihayet Bayraktar3, Şerif Ercan4
1Department of Biochemistry, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey
2Department of Biochemistry, Ankara City Hospital, Ankara, Turkey
3Department of Biochemistry, Faculty of Medicine, Harran University, Sanliurfa, Turkey
4Department of Biochemistry, Lüleburgaz State Hospital, Kırklareli, Turkey
*Corresponding author: mujganercan@hotmail.com
©Copyright by Croatian Society of Medical Biochemistry and Laboratory Medicine. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creative-
commons.org/licenses/by/4.0/) which permits users to read, download, copy, distribute, print, search, or link to the full texts of these articles in any medium or format and to remix, transform and build upon 
the material, provided the original work is properly cited and any changes properly indicated .
Introduction
Today, laboratory results are known to have con-
siderable effect on clinical decision-making. Sam-
ple quality ensured by appropriate sampling tech-
niques is critical in order to obtain accurate results. 
Errors occurring in the preanalytical phase are ac-
cepted as the main source leading to erroneous 
results (1). In vitro haemolysis is one of the most 
common preanalytical error affecting many test 
results. Release of haemoglobin (Hb) and the other 
intracellular contents secondary to impaired mem-
brane integrity of red blood cells (RBC) may cause 
artifactually increase or decrease results. Inappro-
priate techniques for collection, transport and pro-
cessing of samples are the major causes of in vitro 
haemolysis. Haemolysis may simply be detected 
by visual inspection of the serum or plasma com-
ponent of the sample when it contains enough 
quantity of Hb to notice. More recently, automated 
analysers can quantify cell-free Hb by photometric 
measurement at different wavelengths following 
centrifugation (2-9). 
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However, recognition of haemolysis before analy-
sis is unlikely and impractical for complete blood 
count (CBC) as whole blood specimens are used. 
For this reason concomitant serum or plasma sam-
ples may be evaluated for haemolysis or dramati-
cally increased mean corpuscular haemoglobin 
concentration (MCHC) may be used as warning for 
the prevention of unnoticed haemolysis (10,11). 
Determining the effect of haemolysis on CBC pa-
rameters is crucial. Accordingly, defining limits to 
release the results safely or rejecting the sample to 
avoid related undesirable events may be achieved. 
To date, only a few studies have investigated the 
effect of haemolysis on CBC parameters. The Alini-
ty hq analyser (Abbott, Santa Clara, USA) employs 
optical scatter and fluorescence technologies as 
well as cyanide-free absorption haemoglobinom-
etry to perform CBC (12). Multi angle polarized 
scatter separation (MAPSS) technology used in 
this system utilizes seven light scatter detectors 
and a fluorescence detector to collect a unique 
signal signature on each cell, without using im-
pedance technic (12). To the best of our knowl-
edge, there is no interference study related with 
this recently released device in the literature. 
Therefore, the current study aimed to assess the 
interference of in vitro haemolysis on complete 
blood count using Abbott Alinity hq system, and 
to determine which haemolysis levels affect the 
reliability of sample results. 
Materials and methods
Subjects
This cross-sectional study was conducted at Har-
ran University Faculty of Medicine, Biochemistry 
Laboratory. A total of 25 volunteers were included 
in the study between January and March 2021. 
Ethical approval was taken for the study protocol 
from the Ethical committee of Harran University 
Faculty of Medicine and written informed consent 
was obtained from all participants (Approval Num-
ber: 14.09.2020/ HRU/20.16.10).
Methods 
Blood samples were drawn into two 3.0 mL evacu-
ated tubes containing K3- ethylenediaminetet-
raacetic acid (EDTA) (Ref number:IST413) (Isotherm, 
Istanbul, Turkey) and mixed gently immediately af-
ter collection. Samples were portioned in order to 
obtain four aliquots of 1.5 mL from each subject 
subsequently. The first aliquot did not undergo 
any intervention while the second, third and 
fourth aliquots were passed through a small cali-
bre needle (22 gauge, 0.70x38mm) 2, 4 and 6 
times, respectively in order to produce scalar 
amounts of haemolysis according to the Dimeski 
method (13). Routine CBC was performed in all 
samples on Abbott Alinity hq System (Abbott, 
Santa Clara, USA) using the same batch of reagents 
(Abbott, Santa Clara, USA). We conducted an inter-
nal quality control process using 3 levels of Alinity 
h-series Control 29P (Ref. 04U7212, Abbott, Santa 
Clara, USA) at 20 days. The haematological param-
eters analysed were as follows: white blood cell 
count (WBC), neutrophil (neu), lymphocyte (lym), 
monocyte (mono), eosinophil (eos), red blood cell 
(RBC), haemoglobin (Hb), haematocrit (HCT), mean 
corpuscular volume (MCV), mean corpuscular hae-
moglobin (MCH), mean corpuscular haemoglobin 
concentration (MCHC), red cell distribution width 
(RDW), platelet (PLT) and mean platelet volume 
(MPV).
Afterwards, all aliquots were centrifuged at 1000xg 
for 10 minutes. Haemolysis index was measured in 
plasma samples on Siemens Atellica CH chemistry 
analyser (Siemens Healthineers, Erlangen, Germa-
ny). The HI had 7 semi-quantitative values (0 – 6) 
corresponding to Hb concentrations of ≤ 0.10, 0.11-
1.30, 1.31-2.49, 2.50-4.99, 5.00-7.49, 7.50-9.99 and 
≥ 10 g/L, respectively. All samples were grouped 
according to HI values.  
Statististical analysis
The Bland-Altman plot analysis is used to asses the 
biases between the results of paired groups. Effect 
of haemolysis interference was evaluated accord-
ing to the analytical performance specifications 
(APS) for desirable bias as obtained from the Euro-
pean Federation of Clinical Chemistry and Labora-
https://doi.org/10.11613/BM.2021.030706 Biochem Med (Zagreb) 2021;31(3):030706 
  3
Ercan M. et al. Influence of in vitro haemolysis on complete blood count
tory Medicine (EFLM) European Biological Varia-
tion Study (14). Reference change values (RCVs) 
were accepted as clinically acceptable limit and 
derived from within-subject biological variation 
(CVW) and analytical variation (CVA) with the for-
mula: RCV = ± 1.96 x (CVA2 + CVW2) ½ (15). Total CVA 
was estimated from the results of internal quality 
control at three concentration levels. Data analy-
ses were performed using MedCalc Statistical Soft-
ware version 19.1 (MedCalc Software Ltd, Ostend, 
Belgium).
Results 
At the beginning, the study included a hundred 
portions with non-pathological results. Later, 16 
portions were excluded from the study because 
plasma volumes obtained after CBC testing were 
inadequate for the assessment of HI. Twenty-five 
portions had no haemolysis and classified as HI 0 
(Hb concentration: < 0.10 g/L, N = 25). The samples 
were presented as 5 groups according to the HI 
values; Group 1: HI 1 (Hb concentration: 0.11-1.30 
g/L, N = 10), Group 2: HI 2 (Hb concentration: 1.31-
2.49 g/L, N = 17), Group 3: HI 3 (Hb concentration: 
2.50-4.99 g/L, N = 16), Group 4: HI 4 (Hb concentra-
tion: 5.00-7.49 g/L, N = 7), and group 5: HI 6 (Hb 
concentration: > 10.00 g/L, gross haemolysis, N = 
9). There were no samples with HI 5 (Hb concentra-
tion 7.50–10.0 g/L). As the degree of haemolysis 
was different among the samples due to mechani-
cal trauma and to determine the relative percent 
bias accurately HI 0 groups were paired separately 
for each group from the non-haemolysed portions 
(N = 25). Bias percentages and confidence inter-
vals determined for each paired group are pre-
sented in Table 1.
In group 1 there was no significant difference in 
any of the measured parameters.
Results of group 2 showed that at HI 2 all the pa-
rameters, with the exception of MCHC, had altera-
tions meeting the APSs. Percent bias of MCHC 
[0.47 (- 0.4 to 1.33)] was slightly higher than the er-
ror limit (± 0.4%) defined according to EFLM data-
base but was still acceptable when evaluated ac-
cording to RCV (4.12%). 
In group 3, lymphocyte count and MCHC results 
had percent bias values: 7.26 (2.84 to 11.68) and 
0.73 (- 0.13 to 1.58) above the APS related error lim-
its (± 6.3 and ± 0.4, respectively), but they were ac-
ceptable in terms of RCVs (31.00% and 4.12%, re-
spectively).
Group 4 demonstrated that for the lymphocyte 
count, MCH and MCHC parameters, the percent 
bias 7.42 (1.45 to 9.08), 2.59 (1.37 to 3.80) and 2.81 
(1.61 to 4.03) were exceeding the analytical limits 
(± 6.3%, ± 1.35% and ± 0.4%, respectively) but all 
values were acceptable according to RCVs. 
For the grossly haemolysed group 5, lymphocyte 
counts had percent bias of 11.60 (5.57 to 17.62) ex-
ceeding the analytically desirable limit (± 6.3%) 
but were still lower than RCV (31%). RBC count and 
HCT were significantly decreased in grossly 
haemolysed (HI 6) samples as compared with non-
haemolysed ones. The percent bias results of RBC 
count and HCT (- 4.07 (- 5.52 to - 2.62) and - 4.56 (- 
6.13 to - 3.00), respectively) were higher than the 
analytical bias goals (± 1.8% and ± 1.5%, respec-
tively) but under the RCVs (7.46% and 8.11%). How-
ever, the results of MCH and MCHC in this group 
were affected significantly according to both of 
the error limits. 
Discussion 
We observed that the effect of 0.11 to 7.49 g/L Hb 
concentration on CBC parameters were accepta-
ble comparing to the analytical biases with the ex-
ceptions of lymphocytes, MCH, and MCHC. In ad-
dition, all the parameters were within RCVS. On the 
other hand, gross haemolysis (> 10.00 g/L Hb con-
centration) led to decreases in HCT, RBC count and 
an increase in lymphocyte count higher than the 
desirable bias. Moreover, variations in MCH and 
MCHC were exceeding the RCVs. Investigation of 
the impact of haemolysis on CBC is an important 
requirement. To our knowledge, this is the first 
study assessing the haemolysis interference in re-
lation to both analytically and clinically significant 
error limits on the Abbott Alinity hq system. 
In the present study, the effect of haemolysis on 
PLT count has increased in parallel to the degree of 
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Table 1. The effects of haemolysis on complete blood count
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haemolysis. However, it was found to be insignifi-
cant comparing to both analytical and clinical er-
ror limits. On the other hand, De Jonge et al. indi-
cated that haemolysis caused 7.3% (- 34.2% to 
48.7%) and 42.6% (- 16.8% to 101.9%) bias for PLT 
count at mild and high degree, respectively (11). In 
another study it was reported that PLT count was 
biased 18.1% (4.2% to 32%) and 40.6% (20.1% to 
61.1%) at mild and high degrees of haemolysis (16). 
One of the possible explanations to this discrepan-
cy between these studies and our study may be 
the different analytical methodologies used. In the 
study by De Jonge et al. impedance principle was 
used (11). Platelets were counted within a specific 
size range based on the detection of pulses corre-
sponding to the individual cell volume. Since the 
cell size was the only discriminator and both eryth-
rocytes and PLTs were analysed in the same count-
ing chamber of the analyser, it was suggested that 
non-platelet particles such as fragmented erythro-
cytes caused falsely increased PLT counts (17). In 
the study by Lippi et al., optical light scatter tech-
nique was applied for PLT enumeration (16). The 
instrument had two detectors for the measure-
ment of low and high angle scattered light ensur-
ing two-dimensional PLT analysis. However, the ar-
tifactual increase determined in PLT count was at-
tributed to the interference of broken red blood 
cells and their cytoplasmic fragments (18,19). In 
the present study PLT count was also determined 
by an analyser using optical technique. However, 
this instrument performs measurements at multi-
ple angles with additional detectors for better dis-
crimination. 
When RBC counts were evaluated, an analytically 
significant negative bias was observed for grossly 
haemolysed samples. Calculated RBC parameters 
like HCT, MCH and MCHC were also affected due 
to this decrease in RBC. These results were in com-
pliance with the previous studies (11,16). Most re-
markable variations were detected for MCH and 
MCHC in gross haemolysis group exceeding the al-
lowable analytical and clinical bias. 
It is reasonable to assume that cell lysis can direct-
ly affect RBC count and related indices. However, 
almost no significant error was determined at HI 
values lower than 4 (Hb concentration: 0.11-4.99 
g/L) with the exception of MCHC. This was sup-
porting the findings of De Jonge et al. presenting 
none of RBC parameter outside the acceptable 
limit at mild haemolysis group obtained by 5 aspi-
rations through a fine needle (11). On the other 
hand, Lippi et al. found higher bias than the desir-
able bias for these parameters at mild haemolysis 
group produced by 5 aspirations corresponding to 
a Hb concentration between 4.0-4.5 g/L (16). The 
possible explanation to this discrepancy might be 
the difference in the number of times samples 
passed through the needle to generate mechani-
cal haemolysis. In the present study 2, 4 and 6 
times of aspirations caused samples to be haemo-
lysed at 5 different HI levels; which probably 
caused by the variabilities among the fragilities of 
RBC membranes and their different response to 
trauma. According to the manufacturer’s instruc-
tion, approximate concentration ranges for HI val-
ue 1 and 2 were accepted as 0.11-1.30g/L Hb and 
1.31-2.49 g/L Hb, respectively. These values were 
lower than corresponding concentrations ex-
pressed in study by Lippi et al. (16). Index value of 
3, which corresponds to a range of 2.50-4.99 g/L 
Hb concentration, was relatively similar to the pre-
vious study’s mild haemolysis category. However, 
this range was also relatively wide and heteroge-
neous when compared to 4.0-4.5 g/L Hb concen-
tration.  
In the Hb analysis, RBCs were lysed using a reagent 
and released Hb was measured with absorption 
photometry. Haemoglobin measurement was not 
affected from haemolysis because the method 
was not specific for intracellular or free Hb. This 
finding was concordant with the previous studies 
(11,16). 
The results of this study showed that MCV and 
RDW (%) were not interfered significantly with 
haemolysis comparing to the desirable analytical 
and clinical bias criteria. This finding was incom-
patible with the previous studies (11,16). However, 
these two parameters are known to be interrelat-
ed and somewhat dependent to the technology 
used to measure MCV. In addition, the lack of har-
monization between manufacturers in volume 
distribution curve measurement methodologies, 
particularly related to exclusion of extreme values 
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from the distribution, is suggested to result in dif-
ferences between analytical systems (20). 
Evaluation of WBC counts did not show significant 
bias in any of the haemolysis groups. Neverthe-
less, differential analysis revealed that haemolysis 
led to a positive bias on lymphocytes higher than 
desirable analytical bias in group 3, 4 and 5. On the 
other hand, this impact was not significant com-
paring with RCV.
The present study has some limitations. First, the 
sample size was relatively low. The study did not 
include HI 5 (Hb concentration: 7.50-9.99 g/L). In 
addition, the different reactions of the erythrocyte 
membranes of different samples to mechanical 
trauma might have been generalized with a wider 
study group. The second limitation of our study is 
that we could not find the possibility to evaluate 
haemolysis in pathological specimens. 
In conclusion, gross haemolysis (Hb concentration 
> 10 g/L) is likely to produce unreliable CBC results 
in non-pathological samples. Further studies in-
cluding pathological specimens are needed.
Potential conflict of interest
None declared.
References
1. Atay A, Demir L, Cuhadar S, Saglam G, Unal H, Aksun S, et al. 
Clinical biochemistry laboratory rejection rates due to va-
rious types of preanalytical errors. Biochem Med (Zagreb). 
2014;24:376-82. https://doi.org/10.11613/BM.2014.040 
2. Lippi G, Blanckaert N, Bonini P, Green S, Kitchen S, Palicka V, 
et al. Haemolysis: an overview of the leading cause of unsui-
table specimens in clinical laboratories. Clin Chem Lab Med. 
2008;46:764-72. https://doi.org/10.1515/CCLM.2008.170 
3. Lippi G. Systematic assessment of the hemolysis index: 
pros and cons. Adv Clin Chem. 2015;71:157-70. https://doi.
org/10.1016/bs.acc.2015.05.002 
4. Marques-Garcia F. Methods for hemolysis interference study 
in laboratory medicine–a critical review. EJIFCC. 2020;31:85-97.
5. Booth J, Pinney J, Davenport A. Changes in red blo-
od cell size and red cell fragmentation during hemo-
dialysis. Int J Artif Organs. 2010;33:900-5. https://doi.
org/10.1177/039139881003301209 
6. Abed R. Rate of Hematology Specimens Rejection, Associati-
on with area of collection and reason of rejection. Int J Biol 
Med Res. 2013;4:2902-4.
7. Plebani M. The detection and prevention of errors in labo-
ratory medicine. Ann Clin Biochem. 2010;47:101-10. https://
doi.org/10.1258/acb.2009.009222 
8. Lippi G, Blanckaert N, Bonini P, Green S, Kitchen S, Palic-
ka V, et al. Causes, consequences, detection, and preventi-
on of identification errors in laboratory diagnostics. Clin 
Chem Lab Med. 2009;47:143-53. https://doi.org/10.1515/
CCLM.2009.045 
9. Lippi G, Pavesi F, Benegiamo A, Pipitone S. What do he-
molyzed whole-blood specimens look like? Analysis 
with a CellaVision DM96 automated image analysis 
system. J Lab Autom. 2015;20:60-3. https://doi.
org/10.1177/2211068214559644 
10. Lippi G, Plebani M, Di Somma S, Cervellin G. Hemolyzed spe-
cimens: a major challenge for emergency departments and 
clinical laboratories. Crit Rev Clin Lab Sci. 2011;48:143-53. 
https://doi.org/10.3109/10408363.2011.600228 
11. de Jonge G, Dos Santos TL, Cruz BR, Simionatto M, Bitten-
court JI, Krum EA, et al. Interference of in vitro hemolysis 
complete blood count. J Clin Lab Anal. 2018;32:e22396. 
https://doi.org/10.1002/jcla.22396 
12. Woo KS, Jeong IH, An GD, Lim HH, Han JY. Performance eva-
luation of new Abbott Alinity hq hematology analyzer. Int 
J Lab Hematol. 2019;41:657-63. https://doi.org/10.1111/
ijlh.13082 
13. Dimeski G. Effects of hemolysis on the Roche ammonia 
method for Hitachi analyzers. Clin Chem. 2004;50:976-7. 
https://doi.org/10.1373/clinchem.2003.028993 
14. Aarsand AK, Fernandez-Calle P, Webster C, Coskun A, Gon-
zales-Lao E, Diaz-Garzon J, et al. The EFLM Biological Varia-
tion Database. Available at: https://biologicalvariation.eu/. 
Accessed August 25th 2021.
15. Fraser CG. Reference change values. Clin Chem Lab Med. 
2011;50:807-12. https://doi.org/10.1515/cclm.2011.733 
16. Lippi G, Musa R, Avanzini P, Aloe R, Pipitone S, Sandei F. In-
fluence of in vitro hemolysis on hematological testing on 
Advia 2120. Int J Lab Hematol. 2012;34:179-84. https://doi.
org/10.1111/j.1751-553X.2011.01378.x 
17. Briggs C, Kunka S, Machin S. The most accurate platelet co-
unt on the Sysmex XE-2100. Optical or impedance? Clin Lab 
Haematol. 2004;26:157-8. https://doi.org/10.1111/j.1365-
2257.2004.00596.x 
18. Briggs C, Harrison P, Machin S. Continuing developments 
with the automated platelet count. Int J Lab Hema-
tol. 2007;29:77-91. https://doi.org/10.1111/j.1751-
553X.2007.00909.x 
19. Mannuß S. Influence of different methods and anti-
coagulants on platelet parameter measurement. J 
Lab Med. 2020;44:255-72. https://doi.org/10.1515/
labmed-2020-0037 
20. Lippi G, Pavesi F, Bardi M, Pipitone S. Lack of harmonizati-
on of red blood cell distribution width (RDW). Evaluation of 
four hematological analyzers. Clin Biochem. 2014;47:1100-
3. https://doi.org/10.1016/j.clinbiochem.2014.06.003 
